Cancer BiologyLeukemiaPeer-reviewed
Targeting of ibrutinib resistance driving pathways by miR-28 in ABC-DLBCL
Emigdio Álvarez-Corrales, Rocío Moreno-Palomares, Carmen Gómez‐Escolar…·Virginia G. de Yébenes
This study shows miR-28 inhibits ibrutinib resistance in ABC-DLBCL by targeting mitochondrial and mTOR pathways and improves survival in treated patients.
2 citationstop 4%